Avogaro A, Fadini GP. Microvascular complications in diabetes: a growing concern for cardiologists. Int J Cardiol. 2019;291:29–35. https://doi.org/10.1016/j.ijcard.2019.02.030.
Bourne RRA, Jonas JB, Bron AM, Cicinelli MV, Das A, Flaxman SR, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2018;102:575–85. https://doi.org/10.1136/bjophthalmol-2017-311258.
Jackson W. Improving diabetic retinopathy screening. Diabetes Care. 2002;25:1477–8. https://doi.org/10.2337/diacare.25.8.1477.
Kashim RM, Newton P, Ojo O. Diabetic retinopathy screening: a systematic review on patients’ non-attendance. Int J Environ Res Public Health. 2018;15:157. https://doi.org/10.3390/ijerph15010157.
Article PubMed PubMed Central Google Scholar
Bebu I, Lachin JM. Optimal screening schedules for disease progression with application to diabetic retinopathy. Biostatistics. 2018;19:1–13. https://doi.org/10.1093/biostatistics/kxx009.
Miller DJ, Cascio MA, Rosca MG. Diabetic retinopathy: the role of mitochondria in the neural retina and microvascular disease. Antioxidants (Basel). 2020;9:905. https://doi.org/10.3390/antiox9100905.
Article CAS PubMed Google Scholar
Al-Shabrawey M, Smith S. Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers. EPMA J. 2010;1:56–72. https://doi.org/10.1007/s13167-010-0002-9.
Article PubMed PubMed Central Google Scholar
Hendrick AM, Gibson MV, Kulshreshtha A. Diabetic retinopathy. Prim Care. 2015;42:451–64. https://doi.org/10.1016/j.pop.2015.05.005.
Golubnitschaja O, Potuznik P, Polivka J, Pesta M, Kaverina O, Pieper CC, et al. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach. EPMA J. 2022;13:535–45. https://doi.org/10.1007/s13167-022-00307-z.
Article PubMed PubMed Central Google Scholar
Wang Z, Cao D, Zhuang X, Yao J, Chen R, Chen Y, et al. Diabetic retinopathy may be a predictor of stroke in patients with diabetes mellitus. J Endocr Soc. 2022;6:bvac097. https://doi.org/10.1210/jendso/bvac097.
Eriksson MI, Summanen P, Gordin D, Forsblom C, Shams S, Liebkind R, et al. Cerebral small-vessel disease is associated with the severity of diabetic retinopathy in type 1 diabetes. BMJ Open Diabetes Res Care. 2021;9:e002274. https://doi.org/10.1136/bmjdrc-2021-002274.
Article PubMed PubMed Central Google Scholar
Wat N, Wong RL, Wong IY. Associations between diabetic retinopathy and systemic risk factors. Hong Kong Med J. 2016;22:589–99. https://doi.org/10.12809/hkmj164869.
Article CAS PubMed Google Scholar
Animaw W, Seyoum Y. Increasing prevalence of diabetes mellitus in a developing country and its related factors. PLoS One. 2017;12:e0187670. https://doi.org/10.1371/journal.pone.0187670.
Article CAS PubMed PubMed Central Google Scholar
Tinajero MG, Malik VS. An update on the epidemiology of type 2 diabetes: a global perspective. Endocrinol Metab Clin North Am. 2021;50:337–55. https://doi.org/10.1016/j.ecl.2021.05.013.
Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10:14790. https://doi.org/10.1038/s41598-020-71908-9.
Article CAS PubMed PubMed Central Google Scholar
Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al KJ. Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10:107–11. https://doi.org/10.2991/jegh.k.191028.001.
Article PubMed PubMed Central Google Scholar
International Diabetes Federation IDF Diabetes Atlas 10th, Brussels, Belgium, International Diabetes Federation 2021.
Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022;12:542. https://doi.org/10.3390/biom12040542.
Article CAS PubMed PubMed Central Google Scholar
Stitt AW. The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol. 2003;75:95–108. https://doi.org/10.1016/s0014-4800(03)00035-2.
Article CAS PubMed Google Scholar
Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88:1322–35. https://doi.org/10.2522/ptj.20080008.
Article PubMed PubMed Central Google Scholar
Ling W, Huang Y, Huang Y-M, Fan R-R, Sui Y, Zhao H-L. Global trend of diabetes mortality attributed to vascular complications, 2000–2016. Cardiovasc Diabetol. 2020;19:182. https://doi.org/10.1186/s12933-020-01159-5.
Article PubMed PubMed Central Google Scholar
Tönnies T, Röckl S, Hoyer A, Heidemann C, Baumert J, Du Y, et al. Projected number of people with diagnosed type 2 diabetes in Germany in 2040. Diabet Med. 2019;36:1217–25. https://doi.org/10.1111/dme.13902.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. https://doi.org/10.1016/j.diabres.2019.107843.
Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021;69:2932–8. https://doi.org/10.4103/ijo.IJO_1627_21.
Article PubMed PubMed Central Google Scholar
Jacobs E, Hoyer A, Brinks R, Icks A, Kuß O, Rathmann W. Healthcare costs of type 2 diabetes in Germany. Diabet Med. 2017;34:855–61. https://doi.org/10.1111/dme.13336.
Article CAS PubMed Google Scholar
Lynch JL, Barrientos-Pérez M, Hafez M, Jalaludin MY, Kovarenko M, Rao PV, et al. Country-specific prevalence and incidence of youth-onset type 2 diabetes: a narrative literature review. Ann Nutr Metab. 2020;76:289–96. https://doi.org/10.1159/000510499.
Article CAS PubMed Google Scholar
Shukla UV, Tripathy K. Diabetic retinopathy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
Alemu Mersha G, Alimaw YA, Woredekal AT. Prevalence of diabetic retinopathy among diabetic patients in Northwest Ethiopia-a cross sectional hospital based study. PLoS One. 2022;17:e0262664. https://doi.org/10.1371/journal.pone.0262664.
Article CAS PubMed PubMed Central Google Scholar
Romero-Aroca P, López-Galvez M, Martinez-Brocca MA, Pareja-Ríos A, Artola S, Franch-Nadal J, et al. Changes in the epidemiology of diabetic retinopathy in Spain: a systematic review and meta-analysis. Healthcare (Basel). 2022;10:1318. https://doi.org/10.3390/healthcare10071318v.
Teo ZL, Tham Y-C, Yu M, Chee ML, Rim TH, Cheung N, et al. Global Prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128:1580–91. https://doi.org/10.1016/j.ophtha.2021.04.027.
Pradeepa R, Surendar J, Indulekha K, Chella S, Anjana RM, Mohan V. Relationship of diabetic retinopathy with coronary artery disease in Asian Indians with type 2 diabetes: the Chennai Urban Rural Epidemiology Study (CURES) Eye Study–3. Diabetes Technol Ther. 2015;17:112–8. https://doi.org/10.1089/dia.2014.0141.
Article CAS PubMed Google Scholar
Tan GS, Gan A, Sabanayagam C, Tham YC, Neelam K, Mitchell P, et al. Ethnic differences in the prevalence and risk factors of diabetic retinopathy: the Singapore Epidemiology of Eye Diseases Study. Ophthalmology. 2018;125:529–36. https://doi.org/10.1016/j.ophtha.2017.10.026.
Yang Q-H, Zhang Y, Zhang X-M, Li X-R. Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis. Int J Ophthalmol. 2019;12:302–11. https://doi.org/10.18240/ijo.2019.02.19.
Article PubMed PubMed Central Google Scholar
Cheloni R, Gandolfi SA, Signorelli C, Odone A. Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis. BMJ Open. 2019;9:e022188. https://doi.org/10.1136/bmjopen-2018-022188.
Article PubMed PubMed Central Google Scholar
The world report on vision, World Health Organization (WHO), 2019.
Wykoff CC, Khurana RN, Nguyen QD, Kelly SP, Lum F, Hall R, et al. Risk of blindness among patients with diabetes and newly diagnosed diabetic retinopathy. Diabetes Care. 2021;44:748–56. https://doi.org/10.2337/dc20-0413.
Article PubMed PubMed Central Google Scholar
Wang LZ, Cheung CY, Tapp RJ, Hamzah H, Tan G, Ting D, et al. Availability and variability in guidelines on diabetic retinopathy screening in Asian countries. Br J Ophthalmol. 2017;101:1352–60. https://doi.org/10.1136/bjophthalmol-2016-310002.
Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844–51.
Pandova MG. Diabetic Retinopathy and Blindness: an epidemiological overview. In: Giudice GL, Catalá A, editors. Visual impairment and blindness – what we know and what we have to know. IntechOpen; 2019. https://doi.org/10.5772/intechopen.88756.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858. https://doi.org/10.1016/S0140-6736(18)32279-7.
Lin K-Y, Hsih W-H, Lin Y-B, Wen C-Y, Chang T-J. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12:1322–5. https://doi.org/10.1111/jdi.13480.
Article PubMed PubMed Central Google Scholar
Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BEK. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115:1859–68. https://doi.org/10.1016/j.ophtha.2008.08.023.
留言 (0)